Author

H. F. Rabenau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 1

Frequent Co-Authors

J. Cinatl· 2 shared M. Michaelis· 2 shared S. Ciesek· 2 shared B. Koch· 1 shared C. Ruehl· 1 shared D. Bojkova· 1 shared D. Michel· 1 shared D. Schmidt· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J. Cinatl

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Repurposing of the antibiotic nitroxoline for the treatment of mpox

D. Bojkova, N. Zoeller, M. Tietgen, K. Steinhorst, M. Bechtel, T. Rothenburger, J. D. Kandler, J. Schneider, V. M. Corman, S. Ciesek, H. F. Rabenau, M. N. Wass, S. Kippenberger, S. Göttig, M. Michaelis, J. Cinatl

This study shows nitroxoline, an antibiotic, inhibits mpox virus replication and remains effective against tecovirimat-resistant strains, suggesting it as a repurposing candidate for mpox treatment.

bioRxiv · Dec 29, 2022Microbiology

Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity

N. Kohmer, S. Westhaus, C. Ruehl, S. Ciesek, H. F. Rabenau

The paper evaluates the performance of SARS-CoV-2 IgG antibody tests and finds they show high sensitivity in later infection phases but cross-reactivity with other viruses.

bioRxiv · May 8, 2020 · PreprintMicrobiology

The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation

J.-U. Vogel, S. Schmidt, D. Schmidt, F. Rothweiler, B. Koch, P. C. Baer, H. F. Rabenau, D. Michel, T. Stamminger, M. Michaelis, J. Cinatl

This paper shows eltrombopag inhibits HCMV replication via iron chelation, effective against drug-resistant strains and synergistic with ganciclovir.

bioRxiv · Nov 1, 2019Pharmacology & Toxicology